News

11 de January de 1842

  • Kasznar Leonardos

Life Sciences

Our Life Sciences team is highly familiar with the industry and is greatly experienced in the field, standing at the forefront of pioneering and multidisciplinary cases.

We are able to act in a thorough fashion across questions of the most varied natures, since we rely on the consultancy of a team of professionals that are highly skilled in multiple fields of legal nature in addition to other specialists such as engineers, medical doctors, pharmaceutical experts, biomedical researchers, biologists, chemical engineers, among others.

Our clients’ portfolio comprises domestic and transnational companies acting in the fields of health, medicaments, biological products, pharmaceutical actives, medical devices and health techs, in addition to the fields of cosmetics, foodstuffs and agrochemical products.

You may rely on our assistance to create solutions aimed at customizing and specifically fulfilling the requirements of your company, such as for example:

Back

Last related news

15 de September de 2026

Kasznar Leonardos is recognized by the 4th Edition of the CESA Gender Equity Seal

It is with great pride that we announce that our firm has been recognized in the 4th edition of the CESA Gender Kasznar Leonardos is recognized by the 4th Edition of the CESA Gender Equity Seal

  • Kasznar Leonardos
  • Ler notícia

    14 de September de 2026

    Guidance Note: Brazil – Direct Marketing

    Partner Claudio Barbosa and Attorney  at Law Larissa Martins have recently authored the article “Data Guidance: Brazil – Direct Marketing” for the Guidance Note: Brazil – Direct Marketing

    Ler notícia

    4 de September de 2026

    CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

    On August 27, 2026, the National Council for Advertising Self-Regulation (CONAR) approved, significant updates to the Annex “X” of the Brazilian Advertising CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

    Ler notícia